Acumen Pharmaceuticals, Inc. (ABOS) Earnings
|
Expand Research on ABOS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -23.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/30/26  |
Q425 | N/A | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/12/25 |
Q325 | N/A | -$0.60 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | -$0.68 | -$0.51 | -$0.17 | N/A | N/A | N/A |  | | Details | |
| 5/13/25 | Q125 | -$0.48 | -$0.51 | +$0.03 | N/A | N/A | N/A | | | Details | |
| 3/31/25 |
Q424 | N/A | -$0.49 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/12/24 | Q324 | -$0.50 | -$0.36 | -$0.14 | N/A | N/A | N/A | | | Details | |
| 8/13/24 | Q224 | -$0.34 | -$0.27 | -$0.07 | N/A | N/A | N/A | | | Details | |
| 5/14/24 |
Q124 | N/A | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A |
